Cellular Biomedicine: Biotech Showcase 2016 (Cellular Biomedicine Group) - Jan 30, 2016 - Anticipated initiation of P1/2b trials in multiple indications in China in H1 2016; Anticipated initiation of multicenter trial in cholangiocarcinoma and other indications in 2016
Anticipated new P1/2 trial • Anticipated new trial • Oncology
|